People Science, Inc.
People Science, Inc.
Los Angeles, California, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Consumer Health Study Aims to Evaluate the Safety, Tolerability and Impact of ED02 Probiotic Supplement on Gastrointestinal Outcomes | Gastrointestinal; Gut Health | Active, not recruiting | Not applicable | 2026-04-01 | NCT07423897 | |
| Impact of B. Adolescentis iVS-1 Probiotic on Gastrointestinal Outcomes | Abdominal Pain, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Flatulence, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, Skin and Connective Tissue Diseases, connective tissue disorder, constipation disorder, cutaneous mucinosis, diarrheal disease, digestive system disorder, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 4 | Active, not recruiting | Not applicable | 2026-04-01 | NCT07408518 | |
| Immune Defense Protein Impact On Respiratory Immune Outcomes | Infections, Picornaviridae infectious disease, RNA Virus Infections, Respiration Disorders, common cold, influenza, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Not applicable | 2026-03-12 | NCT07431840 |